Neoadjuvant Gold Nanoshell-Based Photothermal Therapy Combined with Liposomal Doxorubicin in a Mouse Model of Colorectal Cancer
DOI: https://doi.org/10.2147/IJN.S389260
IF: 7.033
2023-02-17
International Journal of Nanomedicine
Abstract:Marina Simón, 1, &ast Jesper Tranekjær Jørgensen, 1, &ast Kamilla Norregaard, 1 Jonas Rosager Henriksen, 2 Gael Clergeaud, 2 Thomas L Andresen, 2 Anders Elias Hansen, 2 Andreas Kjaer 1 1 Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital – Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; 2 Department of Health Technology, Section for Biotherapeutic Engineering and Drug Targeting, Technical University of Denmark, Kongens Lyngby, Denmark &astThese authors contributed equally to this work Correspondence: Andreas Kjaer, Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital – Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark, Email Introduction: Traditional cancer treatments, such as chemotherapy, are often incapable of achieving complete responses as standalone therapies. Hence, current treatment strategies typically rely on a combination of several approaches. Nanoparticle-based photothermal therapy (PTT) is a technique used to kill cancer cells through localized, severe hyperthermia that has shown promise as an add-on treatment to multiple cancer therapies. Here, we evaluated whether the combination of gold nanoshell (NS)-based PTT and liposomal doxorubicin could improve outcome in a mouse model of colorectal cancer. Methods: First, NS-based PTT was performed on tumor-bearing mice. Radiolabeled liposomes were then injected at different timepoints to follow their accumulation in the tumor and determine the ideal injection time after PTT. In addition, fluorescent liposomes were used to observe the liposomal distribution in the tumor after PTT. Finally, we combined PTT and doxorubicin-loaded liposomes and studied the effect of the treatment strategy on the mice by following tumor growth and survival. Results: PTT significantly improved liposomal accumulation in the tumor, but only when the liposomes were injected immediately after the therapy. The liposomes accumulated mostly in regions adjacent to the ablated areas. When PTT was combined with liposomal doxorubicin, the mice experienced a slowdown in tumor growth and an improvement in survival. Conclusion: According to our preclinical study, NS-based PTT seems promising as an add-on treatment for liposomal chemotherapy and potentially other systemic therapies, and could be relevant for future application in a clinical setting. Graphical Keywords: liposomes, PET imaging, chemotherapy, hyperthermia, gold nanoparticles Graphical The approach of combining standard cancer therapeutics to overcome the limitations of each individual treatment has been a focus of scientific research for years. 1,2 Traditional anti-cancer therapies like chemo- and radiotherapy are highly efficient for certain tumor types, but recurrence is still a common issue, as well as the side effects caused by these treatments. 3 Different delivery systems have been developed to overcome rapid clearance, toxicity, and low intracellular absorption when administering therapeutic agents, with the aim of improving drug distribution. 4 Liposomes have shown promise due to some unique properties, such as biodegradability, biocompatibility, hydrophobic and hydrophilic character, and low toxicity in the body. 5 In addition, liposomes can passively reach and accumulate in tumors through the enhanced permeability and retention (EPR) effect, from where they can release the drug in a slow and controlled manner. 6 Photothermal therapy (PTT), a minimally invasive technique for the ablation of solid tumors through local hyperthermia, has shown great potential due to its ability to cause tumor death while sparing surrounding healthy tissues. 7–10 The method relies on light-absorbing nanoparticles, such as gold nanoshells (NS), which are injected into the patient and accumulate in the tumor. When the tumors are irradiated with a source of near-infrared (NIR) light, the nanoparticles transform this light into heat, causing irreversible damage to the malignant cells. 11,12 The NS present high photothermal efficiency and have shown to be biocompatible and non-toxic, making them ideal for PTT. 13,14 In fact, NS-based PTT has already been tested in clinical trials with promising results. 15,16 However, PTT applied as monotherapy is often not sufficient to eradicate an entire tumor mass. Limited drug penetration of photothermal -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology